Paper I — 2024 December (Supplementary) (2019 Scheme) — Qi
2 min read
Paper I
2024 December (Supplementary) (2019 Scheme) · 100 marks · 180 min
Question
The probable clinical diagnosis is
a) Endocarditis
c) Rheumatic heart disease
b) Functional mitral regurgitation
d) Mitral valve prolapse
Qi1 marksMCQs
Answer
- [x] c) Rheumatic heart disease
Given the missing case stem, the combination of answer options across this MCQ set (etiological agent Streptococcus pyogenes, serological test ASO, and long-term penicillin prophylaxis) is most consistent with a patient presenting with chronic valvular damage following (or during) an episode of acute rheumatic fever — i.e., rheumatic heart disease. Endocarditis, functional mitral regurgitation, and mitral valve prolapse are the other listed options but do not fit this specific combination of a Group A streptococcal aetiology with ASO-based serological diagnosis and long-term penicillin secondary prophylaxis, which is the defining management strategy for rheumatic heart disease specifically (to prevent recurrent streptococcal infection and further valvular damage).